Development and characterization of lipidic cochleate containing recombinant factor VIII
- 19 August 2007
- journal article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1768 (11), 2890-2898
- https://doi.org/10.1016/j.bbamem.2007.08.001
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Interaction of dicaproyl phosphatidylserine with recombinant factor VIII and its impact on immunogenicityThe AAPS Journal, 2006
- Lipid Binding Region (2303–2332) is Involved in Aggregation of Recombinant Human FVIII (rFVIII)**Karthik Ramani and Vivek S. Purohit have contributed equally to this work.Journal of Pharmaceutical Sciences, 2005
- Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegenerationJournal of Neurochemistry, 2003
- Pharmacokinetics and tissue distribution after intravenous administration of a single dose of amphotericin B cochleates, a new lipid‐based delivery systemJournal of Pharmaceutical Sciences, 2002
- Hemophilia A-From Basic Science to Clinical PracticeSeminars in Thrombosis and Hemostasis, 2002
- Structural and functional characterization of B-domain deleted recombinant factor VIIISeminars in Hematology, 2001
- Targeted disruption of the mouse factor VIII gene produces a model of haemophilia ANature Genetics, 1995
- Biological Regulation of Factor VIII ActivityAnnual Review of Medicine, 1992
- Assay of Factor VIII:C with a Chromogenic SubstrateScandinavian Journal of Haematology, 1984
- METHODOLOGY OF THE ONE‐STAGE ASSAY OF FACTOR VIII(VIII:C)Scandinavian Journal of Haematology, 1984